Polarean Imaging plc (AIM: POLX)
1.550
-0.025 (-1.59%)
Sep 11, 2024, 4:35 PM GMT+1
Polarean Imaging Company Description
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polariser devices in Canada, the United Kingdom, and the United States.
It engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform.
The company also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags.
Polarean Imaging plc was incorporated in 2016 and is based in London, the United Kingdom.
Polarean Imaging plc
Country | United Kingdom |
Founded | 2016 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 29 |
CEO | Christopher Von Jako |
Contact Details
Address: 27-28 Eastcastle Street London, W1W 8DH United Kingdom | |
Website | polarean.com |
Stock Details
Ticker Symbol | POLX |
Exchange | London Stock Exchange AIM |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | GB00BF3DT583 |
SIC Code | 3821 |
Key Executives
Name | Position |
---|---|
Christopher Von Jako | Chief Executive Officer |
Charles Osborne | Chief Financial Officer |
Neil Wadehra | Chief Operating Officer |